| Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression H Lin, S Wei, EM Hurt, MD Green, L Zhao, L Vatan, W Szeliga, R Herbst, ... The Journal of clinical investigation 128 (2), 805-815, 2018 | 561 | 2018 |
| Effector T cells abrogate stroma-mediated chemoresistance in ovarian cancer W Wang, I Kryczek, L Dostál, H Lin, L Tan, L Zhao, F Lu, S Wei, T Maj, ... Cell 165 (5), 1092-1105, 2016 | 391 | 2016 |
| DEDD interacts with PI3KC3 to activate autophagy and attenuate epithelial–mesenchymal transition in human breast cancer Q Lv, W Wang, J Xue, F Hua, R Mu, H Lin, J Yan, X Lv, X Chen, ZW Hu Cancer research 72 (13), 3238-3250, 2012 | 182 | 2012 |
| TRB3 interacts with SMAD3 promoting tumor cell migration and invasion F Hua, R Mu, J Liu, J Xue, Z Wang, H Lin, H Yang, X Chen, Z Hu Journal of cell science 124 (19), 3235-3246, 2011 | 151 | 2011 |
| TRB3 links insulin/IGF to tumour promotion by interacting with p62 and impeding autophagic/proteasomal degradations F Hua, K Li, JJ Yu, XX Lv, J Yan, XW Zhang, W Sun, H Lin, S Shang, ... Nature communications 6 (1), 7951, 2015 | 143 | 2015 |
| Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapy J Li, W Wang, Y Zhang, M Cieślik, J Guo, M Tan, MD Green, W Wang, ... The Journal of clinical investigation 130 (5), 2712-2726, 2020 | 128 | 2020 |
| LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy G Li, I Kryczek, J Nam, X Li, S Li, J Li, S Wei, S Grove, L Vatan, J Zhou, ... Nature cell biology 23 (5), 526-537, 2021 | 115 | 2021 |
| Loss of immunity‐supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll‐like receptor 2‐deficient mice H Lin, J Yan, Z Wang, F Hua, J Yu, W Sun, K Li, H Liu, H Yang, Q Lv, ... Hepatology 57 (1), 171-182, 2013 | 110 | 2013 |
| Blocking TLR2 activity attenuates pulmonary metastases of tumor HZ Yang, B Cui, HZ Liu, S Mi, J Yan, HM Yan, F Hua, H Lin, WF Cai, ... PloS one 4 (8), e6520, 2009 | 109 | 2009 |
| BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells JM Yu, W Sun, F Hua, J Xie, H Lin, DD Zhou, ZW Hu Cancer letters 365 (2), 190-200, 2015 | 101 | 2015 |
| Stanniocalcin 1 is a phagocytosis checkpoint driving tumor immune resistance H Lin, I Kryczek, S Li, MD Green, A Ali, R Hamasha, S Wei, L Vatan, ... Cancer Cell 39 (4), 480-493. e6, 2021 | 91 | 2021 |
| Autophagy and the immune response B Cui, H Lin, J Yu, J Yu, Z Hu Autophagy: Biology and Diseases: Basic Science, 595-634, 2019 | 88 | 2019 |
| Toll‐like receptor 4 activity protects against hepatocellular tumorigenesis and progression by regulating expression of DNA repair protein Ku70 in mice Z Wang, J Yan, H Lin, F Hua, X Wang, H Liu, X Lv, J Yu, S Mi, J Wang, ... Hepatology 57 (5), 1869-1881, 2013 | 65 | 2013 |
| The ubiquitin ligase MDM2 sustains STAT5 stability to control T cell-mediated antitumor immunity J Zhou, I Kryczek, S Li, X Li, A Aguilar, S Wei, S Grove, L Vatan, J Yu, ... Nature immunology 22 (4), 460-470, 2021 | 61 | 2021 |
| A combined strategy improves the solubility of aggregation-prone single-chain variable fragment antibodies W Sun, J Xie, H Lin, S Mi, Z Li, F Hua, Z Hu Protein expression and purification 83 (1), 21-29, 2012 | 60 | 2012 |
| Antioxidant N-acetylcysteine attenuates hepatocarcinogenesis by inhibiting ROS/ER stress in TLR2 deficient mouse H Lin, X Liu, J Yu, F Hua, Z Hu PLoS One 8 (10), e74130, 2013 | 55 | 2013 |
| Targeting acute myeloid leukemia with a proapoptotic peptide conjugated to a toll‐like receptor 2‐mediated cell‐penetrating peptide K Li, XX Lv, F Hua, H Lin, W Sun, WB Cao, XM Fu, J Xie, JJ Yu, Z Li, H Liu, ... International journal of cancer 134 (3), 692-702, 2014 | 54 | 2014 |
| Repairing DNA damage by XRCC6/KU70 reverses TLR4-deficiency-worsened HCC development via restoring senescence and autophagic flux Z Wang, H Lin, F Hua, Z Hu Autophagy 9 (6), 925-927, 2013 | 53 | 2013 |
| Autophagic flux, supported by toll-like receptor 2 activity, defends against the carcinogenesis of hepatocellular carcinoma H Lin, F Hua, ZW Hu Autophagy 8 (12), 1859-1861, 2012 | 37 | 2012 |
| Glycogen synthase kinase-3β negatively regulates TGF-β1 and Angiotensin II-mediated cellular activity through interaction with Smad3 F Hua, J Zhou, J Liu, C Zhu, B Cui, H Lin, Y Liu, W Jin, H Yang, Z Hu European journal of pharmacology 644 (1-3), 17-23, 2010 | 32 | 2010 |
